Publications by authors named "Pavel Tatarskyy"

Tardive dyskinesia (TD) is an adverse movement disorder induced by chronic treatment with antipsychotics drugs. The contribution of common genetic variants to TD susceptibility has been investigated in recent years, but with limited success. The aim of the current study was to investigate the potential contribution of rare variants to TD vulnerability.

View Article and Find Full Text PDF
Article Synopsis
  • The Ahi1 gene is crucial for brain development and is linked to schizophrenia and other neuropsychiatric disorders.
  • Research using genetically modified mice (Ahi1+/-) indicates they exhibit reduced anxiety responses and altered brain connectivity, but it was unclear if this was due to resilience or cognitive deficits.
  • Studies showed that while wild-type mice were negatively affected by chronic stress, Ahi1+/- mice remained largely unaffected, suggesting Ahi1 under-expression during development may lead to a lack of stress responsiveness and altered brain function.
View Article and Find Full Text PDF

We performed whole exome or genome sequencing in eight multiply affected families with ostensibly isolated congenital anosmia. Hypothesis-free analyses based on the assumption of fully penetrant recessive/dominant/X-linked models obtained no strong single candidate variant in any of these families. In total, these eight families showed 548 rare segregating variants that were predicted to be damaging, in 510 genes.

View Article and Find Full Text PDF

Bilateral common carotid artery stenosis (BCAS) models the effects of compromised cerebral blood flow on brain structure and function in mice. We compared the effects of BCAS in aged (21 month) and young adult (3 month) female mice, anticipating a differentially more severe effect in the older mice. Four weeks after surgery there was a significant age by time by treatment interaction on the radial-arm water maze (RAWM; = 0.

View Article and Find Full Text PDF

Pemphigus vulgaris (PV) is a life-threatening autoimmune mucocutaneous blistering disease caused by disruption of intercellular adhesion due to auto-antibodies directed against epithelial components. Treatment is limited to immunosuppressive agents, which are associated with serious adverse effects. The propensity to develop the disease is in part genetically determined.

View Article and Find Full Text PDF